News Author: Sara Freeman Publish date: April 26, 2017
BIRMINGHAM, ENGLAND – Naproxen may be considered the first-choice treatment for patients with acute gout in primary care, based on results of the C...
News Author: Sara Freeman Publish date: April 25, 2017
AMSTERDAM – The ANSWER study showed long-term albumin administration to patients with decompensated cirrhosis may be seen as a disease-modifying tr...
News Author: Sara Freeman Publish date: April 23, 2017
AMSTERDAM – An estimated 328 million people worldwide were living with chronic hepatitis B or C virus infection in 2015 according to a new report i...
Article Author: Sara Freeman Publish date: December 13, 2016
VIENNA – Stereotactic body radiotherapy (SBRT) proved too toxic for many of patients recruited into a multinational phase II trial with centrally-l...
Article Author: Sara Freeman Publish date: December 12, 2016
VIENNA – The investigational agent alisertib plus paclitaxel improved progression-free survival, compared with paclitaxel plus placebo, in pa...
Article Author: Sara Freeman Publish date: December 8, 2016
VIENNA – In a heavily pretreated population of patients with non–small-cell lung cancer, the investigational checkpoint inhibitor durva...
Article Author: Sara Freeman Publish date: December 7, 2016
VIENNA – One-third of patients with extensive-stage small-cell lung cancer (SCLC) treated with the checkpoint inhibitor pembrolizumab achieve...
Article Author: Sara Freeman Publish date: December 6, 2016
VIENNA – The addition of ganetespib to docetaxel for the treatment of advanced non–small cell lung cancer (NSCLC) did not live up to it...
Article Author: Sara Freeman Publish date: October 6, 2016
LONDON – Measuring serum levels of the extracellular protein periostin could help identify patients with asthma who have comorbid upper-airwa...
Article Author: Sara Freeman Publish date: October 6, 2016
LONDON – The vast majority of surgical lung biopsies currently used to diagnose interstitial lung diseases (ILDs) could be avoided, suggests ...
Article Author: Sara Freeman Publish date: October 3, 2016
LONDON – Severe vitamin D deficiency and current smoking predicted accumulated disability in patients with clinically isolated syndrome, whic...
Article Author: Sara Freeman Publish date: October 3, 2016
LONDON – Contrary to expectation of a neuroprotective benefit, fluoxetine does not slow down the progressive phase of multiple sclerosis, acc...
Article Author: Sara Freeman Publish date: October 1, 2016
LONDON
News Author: Sara Freeman Publish date: September 29, 2016
LONDON – After 6 months on extended-release dalfampridine, patients with relapsing-remitting multiple sclerosis reported that their ability to walk wa...
News Author: Sara Freeman Publish date: September 22, 2016
Key clinical point:Alemtuzumab and natalizumab are similarly effective at preventing relapse and disability progression in patients with relapsing...
